Works matching IS 2160763X AND DT 2016 AND VI 5 AND IP 3

Results: 11

A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 188, doi. 10.1002/cpdd.233

By:

Suri, Ajit;
Pham, Theresa;
MacLean, David B.

Publication type:

Article

Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 180, doi. 10.1002/cpdd.234

By:

Suri, Ajit;
Pusalkar, Sandeepraj;
Li, Yuexian;
Prakash, Shimoga

Publication type:

Article

Pharmacokinetics of the Long-Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal Function.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 216, doi. 10.1002/cpdd.252

By:

Linnebjerg, Helle;
Choi, Siak Leng;
Lam, Eric Chen Quin;
Mace, Kenneth F.;
Hodgson, Teri S.;
Sinha, Vikram P.

Publication type:

Article

Sex and Food Influence on Intestinal Absorption of Ketoprofen Gastroresistant Formulation.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 196, doi. 10.1002/cpdd.208

By:

Magallanes, Laura;
Lorier, Marianela;
Ibarra, Manuel;
Guevara, Natalia;
Vázquez, Marta;
Fagiolino, Pietro

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 163, doi. 10.1002/cpdd.226
Publication type:: Article

Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 170, doi. 10.1002/cpdd.243

By:

Martin, Paul;
Gillen, Michael;
Millson, David;
Oliver, Stuart;
Brealey, Clive;
Surry, Dominic;
Sweeny, David;
Lau, David;
Leese, Philip

Publication type:

Article

Meldonium (Mildronate): A Performance-Enhancing Drug?

Published in:

2016

By:

Greenblatt, H. Karl;
Greenblatt, David J.

Publication type:

Editorial

Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β<sub>3</sub>-Adrenoceptor Agonist, With Probenecid in Healthy Men.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 201, doi. 10.1002/cpdd.212

By:

Abe, Yoshikazu;
Nakano, Yuki;
Kanazawa, Toru;
Furihata, Takao;
Endo, Takuro;
Kobayashi, Mamoru

Publication type:

Article

Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol- O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 232, doi. 10.1002/cpdd.217

By:

Rocha, José‐Francisco;
Ferreira, Joaquim J.;
Falcão, Amílcar;
Santos, Ana;
Pinto, Roberto;
Nunes, Teresa;
Almeida, Luis;
Soares‐da‐Silva, Patrício

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 225, doi. 10.1002/cpdd.218

By:

Allen, Ann;
Murdoch, Robert D.;
Bareille, Philippe;
Burns, Olivia;
Hughes, Stephen;
Gupta, Ashutosh;
Miller, Sam R.

Publication type:

Article

Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 208, doi. 10.1002/cpdd.219

By:

Struemper, Herbert;
Murtaugh, Thomas;
Gilbert, Jane;
Barton, Matthew E.;
Fire, Joseph;
Groark, James;
Fox, Norma Lynn;
Roth, David;
Gordon, David

Publication type:

Article